Neurocritical ill patients are frequently transfused. Red blood cell transfusion (RBCT) in these patients has been associated with deleterious effects, including higher rates of nosocomial infections, multi-organ failure, and mortality. Therefore, it seems crucial to avoid any unnecessary RBCT. Most critically ill patients tolerate hemoglobin levels near 7 g/dL without an increase in morbidity or mortality rates. In this regard, a recent sub-analysis of TRICC trial has showed that TBI patients may tolerate hemoglobin levels as low as 7 g/dL, but other studies including neurocritical patients suggested that severe anemia may worsen clinical outcome. Therefore, optimal hemoglobin levels in neurocritical care patients remain largely unknown. Some textbooks and guidelines recommend to transfuse these patients to reach hemoglobin levels near to 10 g/dL, despite the lack of a solid scientific background supporting this target. Even though it has not been demonstrated, hemoglobin-based RBCT prescription could result in over- or under-transfusion in neurocritical patients. Alternatively, it has been suggested that more physiological transfusion triggers, using direct signals coming from the brain, will progressively replace arbitrary hemoglobin-based transfusion triggers in the neurocritical patients \[65\]. At the neurocritical units, patients are often monitored by using non-invasive methods, such as near infrared spectroscopy which indirectly measures regional cerebral oxygen saturation (rSO2). Changes in rSO2 values have been shown to directly correlate with changes in erythrocyte mass, thus increasing with RBCT and decreasing with blood losses. Moreover, rSO2 values also show a good correlation with clinical outcome and other variables which are often monitored in TBI patients. The purpose of this study is to ascertain as to whether rSO2 levels are more efficacious than conventional hemoglobin levels in guiding RBCT in patients admitted to a neurocritical care unit.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
102
Patients will be transfused (one to one red blood cells unit transfusion)
Hospital Universitario "Virgen del Rocío"
Seville, Seville, Spain
Number of Units of Packed Red Blood Cell Transfused
Number of units of packed packed red blood cell transfused, over the period that the patient was included into the protocol
Time frame: duration of the protocol, an average of 15 days
Percentage of Transfused Patients in Each Group
Time frame: duration of the protocol, an average of 15 days
Hospital Mortality
Time frame: length of the hospital stay, an average of 20 days
Length of Intensive Care Unit (ICU) Stay
Time frame: The length of ICU stay, an avarege of 17 days
Long-term Mortality
Time frame: 1-year after hospital discharge
Unfavorable Glasgow Outcome Scale (GOS)
GOS measures the degree of disability associated with the brain injury Unfavorable GOS included the categories of: 1. death. 2. vegetative status. 3. severe disability.
Time frame: At hospital discharge, an average of 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.